Relievant Medsystems Launches Innovative Access Instruments to Enhance the Intracept Procedure for Chronic Vertebrogenic Low Back Pain
Saturday, July 15, 2023
Relievant Medsystems, a company focused on advancing the diagnosis and treatment of vertebrogenic low back pain, has recently unveiled their latest innovation: the next-generation Intracept® Access Instruments. These new instruments have been specifically designed to improve the accuracy and efficiency of targeting the basivertebral nerve (BVN) during the proven and safe Intracept® Procedure.
The Intracept Procedure, a minimally invasive treatment for chronic vertebrogenic low back pain, has already benefited over 10,000 patients. It is the only FDA-cleared procedure of its kind and involves using targeted radiofrequency energy to disrupt the transmission of pain signals from the BVN to the brain. The entire procedure can be completed in approximately one hour and is performed on an outpatient basis.
The next-generation Intracept Access Instruments have been carefully developed to ensure consistent performance across different bone densities. They include Bevel and Diamond Introducers that provide reliable access and feature a depth marker for precise positioning. The Curved Cannula Assembly with J-Stylet allows for accurate steerability, enabling a predictable path to the BVN. Additionally, the Straight Stylet offers efficient extension or adjustment of the access path trajectory. Another improvement is the flexible shaft incorporated into the Intracept® RF Probe, which enhances C-arm operating clearance during the procedure.
Chronic low back pain affects an estimated 30 million people in the United States, with around 1 in 6 individuals likely to experience vertebrogenic pain. Vertebrogenic pain is a specific type of chronic low back pain caused by damage to the vertebral endplates, which connect the discs and vertebral bodies. Patients with this condition typically experience pain in the middle of the lower back, which worsens during activities such as bending, prolonged sitting, or physical exertion. Physicians can confirm vertebrogenic pain by identifying Modic changes, observable biomarkers indicating inflammation at the vertebral endplate, through standard MRI scans.